Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Key Genes in Atherosclerosis by Combined DNA Methylation and miRNA Expression Analyses. | Anatol J Cardiol | 2022 | 35949126 | PubTator, text mining | PubMed |
| Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable. | Int J Cardiol Heart Vasc | 2022 | 35942005 | PubTator, text mining | PubMed |
| Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments. | Front Oncol | 2022 | 35936721 | PubTator, text mining | PubMed |
| Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer. | Sci Rep | 2022 | 35927418 | PubTator, text mining | PubMed |
| Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi anemia/homologous recombination pathways. | Hum Mol Genet | 2022 | 35904444 | PubTator, text mining | PubMed |
| Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies-A Review. | Cancers (Basel) | 2022 | 35892827 | PubTator, text mining | PubMed |
| Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series. | J Clin Med | 2022 | 35887731 | PubTator, text mining | PubMed |
| Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study. | Int J Environ Res Public Health | 2022 | 35886551 | PubTator, text mining | PubMed |
| The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease. | Biomedicines | 2022 | 35884797 | PubTator, text mining | PubMed |
| Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. | Cancers (Basel) | 2022 | 35884575 | PubTator, text mining | PubMed |
| Responses to the Tepotinib in Gastric Cancers with MET Amplification or MET Exon 14 Skipping Mutations and High Expression of Both PD-L1 and CD44. | Cancers (Basel) | 2022 | 35884507 | PubTator, text mining | PubMed |
| Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study. | Oncologist | 2022 | 35881043 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome. | Front Immunol | 2022 | 35860235 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia. | Orphanet J Rare Dis | 2022 | 35854323 | PubTator, text mining | PubMed |
| Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma. | Sci Rep | 2022 | 35853969 | PubTator, text mining | PubMed |
| An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases. | JCI Insight | 2022 | 35852875 | PubTator, text mining | PubMed |
| Characterising the interactions between Cu(II) and fulvic acid subcomponents using differential fluorescence spectroscopy combined with parallel factor analysis. | Environ Sci Pollut Res Int | 2022 | 35842512 | PubTator, text mining | PubMed |
| Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. | Cancer Res | 2022 | 35834270 | PubTator, text mining | PubMed |
| DNA repair as a shared hallmark in cancer and ageing. | Mol Oncol | 2022 | 35834102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=24